Dr. Carl Morris is the Chief Scientific Officer for Solid Biosciences, joining the company in September 2015. Dr. Morris is a member of the Senior Management team at Solid Biosciences and is responsible for overseeing the company’s drug discovery and preclinical development efforts. Prior to joining Solid, Dr. Morris was a Senior Director for Pfizer’s Rare Disease Research Unit, leading its biologics and neuromuscular disease area programs. Before moving to industry, he served as an Assistant Professor at the Boston University School of Medicine in the Muscle and Aging Research Unit. Dr. Morris holds a Bachelor of Arts degree in Biology from Franklin Pierce College (NH) and a Ph.D. in Physiology from UCLA.